Developer docs
API playgroundTry for free, no card

Search company profiles

PD Neurotechnology

Full company profile

uuid000c2rr

Namestring
PD Neurotechnology
Legal namestring
PD Neurotechnology Ltd
Company typeenum
Private
Founded yearint
2015
Descriptiontext

PD Neurotechnology is a London-headquartered medical device company founded in 2015 that develops PDMonitor, a CE-marked Class IIa wearable medical device ecosystem for continuous remote monitoring of Parkinson's disease symptoms. The system consists of five wearable sensors worn on the wrists and ankles, a SmartBox docking station, a mobile application, cloud-based storage, and a web-based physician tool. Kinematic data captured by the sensors is processed through proprietary machine learning algorithms developed over more than ten years of research at the University of Ioannina MedLab, enabling detection and quantification of nine motor symptoms including bradykinesia, dyskinesia, tremor, gait disturbances, freezing of gait, orthostatic instability, ON/OFF states, activity levels, and fluctuations. The company targets Parkinson's patients at any stage of disease, the neurologists and movement disorder specialists who treat them, and the caregivers who support daily disease management.

The business model combines direct-to-patient hardware sales with subscription-style access to the cloud platform and physician web tool. Patients purchase the PDMonitor system directly from PD Neurotechnology and are matched with a certified neurologist who monitors their data remotely. Neurologists must complete a structured certification program administered by the company before prescribing, creating a controlled clinical adoption pathway. International distribution is supported through channel partners such as Crimson International Investment, which serves as the exclusive distributor for Gulf countries. Pricing is not publicly disclosed, and insurance coverage is limited (potentially available through major German insurers but not yet broadly established). Operations are split across London (headquarters), Athens (sales and marketing), and Ioannina (R&D, production, distribution, and clinical studies), with R&D supported by a 60+ person academic lab at the University of Ioannina.

The company's research and regulatory footprint is substantial for its size. PDMonitor holds CE Class IIa certification under Directive 93/42/EEC, EU MDR 2017/745 compliance, EN ISO 13485:2016 quality certification, ISO 27001:2022 information security certification, Greek EOF registration, and a conditional NICE recommendation for NHS use in the UK. The company has published five peer-reviewed papers on PDMonitor in 2020 and continues active clinical validation work. Beyond the core PDMonitor product, PD Neurotechnology is developing HealthSonar (a non-invasive sleep and activity monitoring system using low-power radio waves) and the Smart Insole (a novel gait analysis wearable), and participates in the EU Horizon 2020-funded PD_Pal project for advanced Parkinson's care management. The company is privately held, with revenue not publicly disclosed, and remains pre-commercial at scale outside its core Greek and select European markets.

Short descriptiontext

PD Neurotechnology is a London-based medical device company (founded 2015) that develops PDMonitor, a CE-marked Class IIa wearable system using proprietary machine learning to continuously monitor motor symptoms in Parkinson's disease patients for prescribing neurologists.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wearable medical devices, patient monitoring systems, Parkinson's disease technology, movement disorder diagnostics, remote health monitoring
Industry2 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAJ
Neurology RPM (epilepsy, Parkinson’s, MS monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Measuring & Controlling Devices, Nec3829
Product category
Wearable Medical Devices — Parkinson's Disease Monitoring
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1PDMonitor Device Sales
TypeHardware Sales
Description

PD Neurotechnology sells PDMonitor as a medical device directly to patients. Patients purchase the system from the company and are matched with a certified healthcare professional who monitors their condition through the physician tool. The device includes hardware (wearable sensors, SmartBox) and access to the cloud platform and physician tool.

pdneurotechnology.com
2Cloud Platform and Software Services
TypeSubscription Recurring
Description

Patients and physicians access the cloud platform and physician tool for continuous monitoring, data storage, and treatment decision support. Revenue is generated through the sale of the complete PDMonitor system which includes ongoing software and cloud services.

pdneurotechnology.com
3HealthSonar System
TypeHardware Sales
Description

A new non-invasive monitoring system for sleep and healthy living using low power radio wave technologies. Part of the company's expanded product portfolio for health monitoring beyond Parkinson's disease.

pdneurotechnology.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1PDMonitor device and monitoring service
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing not publicly disclosed. Patients obtain the device directly from PD Neurotechnology and are matched with certified healthcare professionals. The company provides pricing information upon contact.

pdneurotechnology.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

PD Neurotechnology develops and sells PDMonitor®, a CE-marked Class IIa medical device ecosystem that continuously monitors Parkinson's disease symptoms in patients' homes. The system consists of five wearable sensors (worn on wrists and ankles), a SmartBox docking station, a mobile application, cloud-based data storage, and a web-based Physician Tool for clinicians. Data is processed through proprietary algorithms and machine learning to objectively track nine motor symptoms and support remote treatment optimization by neurologists.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Certified 30 neurologists from 6 countries (Germany, Italy, Sweden, Ireland, Greece, Cyprus) in PDMonitor usage within a single training initiative
+2 more records
Product overview1 text field

PD Neurotechnology offers the PDMonitor® as its core product—an integrated medical device ecosystem for continuous remote monitoring of Parkinson's disease symptoms. The system comprises five wearable monitoring devices, a SmartBox connection station, a mobile application, cloud-based data storage, and a web-based Physician Tool. The company has also developed HealthSonar for sleep and daily activity monitoring, and participates in research projects including the Smart Insole (for gait analysis) and PD_Pal (European project for advanced Parkinson's care management).

Product and service1 record
1PDMonitor®
CategoryWearable Medical Devices
Description

A CE-marked Class IIa medical device ecosystem for continuous remote monitoring of Parkinson's disease patients. The system comprises five wearable sensors worn on different body parts (wrists and ankles), a SmartBox connection/docking station, a mobile application, cloud-based data storage, and a web-based Physician Tool. It tracks, records, and processes nine motor symptoms — bradykinesia, dyskinesia, tremor, gait disturbances, freezing of gait, orthostatic instability, ON/OFF states, activity, and fluctuations — and is used by patients at home in conjunction with a certified neurologist.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-11
Description

PD Neurotechnology was selected among 9 companies for Endeavor's Scale-Up program, gaining access to strategic guidance from specialized mentors, funding through Endeavor's international investor network, and talent through cooperation with universities and companies internationally.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

PKNM Solutions Sarl served as regulatory advisor throughout the CE certification process for PDMonitor, providing expertise on compliance with Medical Device Directive 93/42/EEC requirements.

3PD_Pal Project Consortium
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PD Neurotechnology participates in the PD_Pal project, a multi-center European project coordinated by University of Padua, developing innovative approaches to Parkinson's care using technology integration. The 4 million Euro EU Horizon 2020 funded project involves King's College London, University College London, University of Nijmegen, University of Ioannina, University of Marburg, and Paracelsus University Salzburg.

pdneurotechnology.com
4HealthSonar Project Consortium
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PD Neurotechnology coordinates the HealthSonar project with partners including FORTH-IESL & ICS (Foundation of Research and Technology Hellas), NKUA (National Kapodistrian University of Athens), FORTH-IMBB, University of Patras, and Medis. The project develops a non-invasive system for monitoring sleep and healthy living using low power radio wave technologies.

pdneurotechnology.com
5Smart Insole Project Consortium
Strategic tierMinorTypeStrategic or Co-development Partner
Description

PD Neurotechnology participates in the Smart Insole project developing a novel wearable sensor for continuous gait analysis using innovative materials and manufacturing methods. Funded under the Greek 'RESEARCH-CREATE-INNOVATE' program with European Regional Development Fund and national resources.

pdneurotechnology.com
6Greek National Organization for Medicines (EOF)
Strategic tierCoreTypeOthers
Description

PDMonitor is officially registered with the Greek National Organization for Medicines (EOF) with registration number 2820003711929, enabling legal sale as a medical product in the Greek market.

pdneurotechnology.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Australian medical device company that developed the Personal KinetiGraph (PKG) wearable watch for objective, continuous measurement of Parkinson's disease motor symptoms. Direct competitor offering a similar wearable monitoring solution targeting neurologists and movement disorder specialists, with established commercial traction in multiple geographies.

TypeDirect peer
Description

US-based company commercializing the Kinesia family of wearable sensors and software for quantitative assessment of Parkinson's disease motor symptoms. Direct competitor with FDA-cleared products, serving movement disorder clinics and clinical trials with similar kinematic-data-driven symptom monitoring.

TypeDirect peer
Description

US medical device company developing wearable neurostimulation therapies (Cala Trio, Cala kIQ) for essential tremor and Parkinson's disease. Direct competitor in the wearable neurology space targeting the same Parkinson's patient population, though focused on therapeutic stimulation rather than monitoring.

TypeDirect peer
Description

UK-based startup developing the CUE1 wearable device for Parkinson's disease symptom relief through focused vibrotactile stimulation. Direct peer operating in the same wearable Parkinson's category from a UK base, targeting the same patient and specialist community with adjacent therapeutic wearable approach.

TypeEmerging player
Description

US digital health company offering StrivePD, an Apple Watch-based Parkinson's monitoring and care platform with FDA clearance and pharma partnerships. Emerging competitor leveraging consumer device distribution rather than proprietary hardware, which represents a different but overlapping approach to continuous Parkinson's symptom monitoring.

TypeEmerging player
Description

French medical device startup developing wearable sensors and AI algorithms for continuous monitoring of Parkinson's disease motor symptoms. Emerging European peer with overlapping wearable/ML approach to objective PD assessment, competing for similar clinical and research customers.

TypeBroad incumbent
Description

Global medical device leader with deep involvement in Parkinson's disease through deep brain stimulation (DBS) systems and increasingly connected care/digital health platforms. Broad incumbent providing an alternative interventional treatment path and increasingly adjacent digital monitoring for PD patients.

TypeBroad incumbent
Description

Global pharmaceutical leader in Parkinson's disease therapeutics (Duopa, Duodopa, Vyalev) and major funder of clinical research including digital biomarker programs. Broad incumbent representing both a competitor in adjacent digital PD solutions and a potential pharma-channel partner for clinical trial endpoints.

TypeBroad incumbent
Description

Global pharmaceutical and diagnostics leader with growing investment in digital health, including the PD Digital Biomarker DREAM Challenge and partnerships around objective Parkinson's measurement. Broad incumbent operating at the intersection of diagnostics and digital biomarkers relevant to PD monitoring.

TypeOthers
Description

Major Parkinson's disease research foundation that funds digital biomarker development, wearable validation studies, and clinical consortia. Acts as an ecosystem participant rather than competitor — relevant because it influences payer validation, research collaborations, and clinical study design across the wearable PD monitoring space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PD Neurotechnology

Wearable Medical Devices — Parkinson's Disease Monitoringpdneurotechnology.com

PD Neurotechnology is a London-based medical device company (founded 2015) that develops PDMonitor, a CE-marked Class IIa wearable system using proprietary machine learning to continuously monitor motor symptoms in Parkinson's disease patients for prescribing neurologists.

What PD Neurotechnology does

PD Neurotechnology is a London-headquartered medical device company founded in 2015 that develops PDMonitor, a CE-marked Class IIa wearable medical device ecosystem for continuous remote monitoring of Parkinson's disease symptoms. The system consists of five wearable sensors worn on the wrists and ankles, a SmartBox docking station, a mobile application, cloud-based storage, and a web-based physician tool. Kinematic data captured by the sensors is processed through proprietary machine learning algorithms developed over more than ten years of research at the University of Ioannina MedLab, enabling detection and quantification of nine motor symptoms including bradykinesia, dyskinesia, tremor, gait disturbances, freezing of gait, orthostatic instability, ON/OFF states, activity levels, and fluctuations. The company targets Parkinson's patients at any stage of disease, the neurologists and movement disorder specialists who treat them, and the caregivers who support daily disease management.

The business model combines direct-to-patient hardware sales with subscription-style access to the cloud platform and physician web tool. Patients purchase the PDMonitor system directly from PD Neurotechnology and are matched with a certified neurologist who monitors their data remotely. Neurologists must complete a structured certification program administered by the company before prescribing, creating a controlled clinical adoption pathway. International distribution is supported through channel partners such as Crimson International Investment, which serves as the exclusive distributor for Gulf countries. Pricing is not publicly disclosed, and insurance coverage is limited (potentially available through major German insurers but not yet broadly established). Operations are split across London (headquarters), Athens (sales and marketing), and Ioannina (R&D, production, distribution, and clinical studies), with R&D supported by a 60+ person academic lab at the University of Ioannina.

The company's research and regulatory footprint is substantial for its size. PDMonitor holds CE Class IIa certification under Directive 93/42/EEC, EU MDR 2017/745 compliance, EN ISO 13485:2016 quality certification, ISO 27001:2022 information security certification, Greek EOF registration, and a conditional NICE recommendation for NHS use in the UK. The company has published five peer-reviewed papers on PDMonitor in 2020 and continues active clinical validation work. Beyond the core PDMonitor product, PD Neurotechnology is developing HealthSonar (a non-invasive sleep and activity monitoring system using low-power radio waves) and the Smart Insole (a novel gait analysis wearable), and participates in the EU Horizon 2020-funded PD_Pal project for advanced Parkinson's care management. The company is privately held, with revenue not publicly disclosed, and remains pre-commercial at scale outside its core Greek and select European markets.

PD Neurotechnology firmographics

Firmographics
Name
PD Neurotechnology
Legal name
PD Neurotechnology Ltd
Website
https://pdneurotechnology.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
PD Neurotechnology is a London-based medical device company (founded 2015) that develops PDMonitor, a CE-marked Class IIa wearable system using proprietary machine learning to continuously monitor motor symptoms in Parkinson's disease patients for prescribing neurologists.
Ownership category
akta.pro rank

PD Neurotechnology industry classification

Industry
Product category
Wearable Medical Devices — Parkinson's Disease Monitoring
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Measuring & Controlling Devices, Nec (3829)
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAJ
Neurology RPM (epilepsy, Parkinson’s, MS monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Wearable medical devices
  • Patient monitoring systems
  • Parkinson's disease technology
  • Movement disorder diagnostics
  • Remote health monitoring

Where PD Neurotechnology is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

PD Neurotechnology business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. PDMonitor Device Sales: PD Neurotechnology sells PDMonitor as a medical device directly to patients. Patients purchase the system from the company and are matched with a certified healthcare professional who monitors their condition through the physician tool. The device includes hardware (wearable sensors, SmartBox) and access to the cloud platform and physician tool.
  2. Cloud Platform and Software Services: Patients and physicians access the cloud platform and physician tool for continuous monitoring, data storage, and treatment decision support. Revenue is generated through the sale of the complete PDMonitor system which includes ongoing software and cloud services.
  3. HealthSonar System: A new non-invasive monitoring system for sleep and healthy living using low power radio wave technologies. Part of the company's expanded product portfolio for health monitoring beyond Parkinson's disease.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goPDMonitor device and monitoring service

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

PD Neurotechnology product offering

Product offering

Core offering

PD Neurotechnology develops and sells PDMonitor®, a CE-marked Class IIa medical device ecosystem that continuously monitors Parkinson's disease symptoms in patients' homes. The system consists of five wearable sensors (worn on wrists and ankles), a SmartBox docking station, a mobile application, cloud-based data storage, and a web-based Physician Tool for clinicians. Data is processed through proprietary algorithms and machine learning to objectively track nine motor symptoms and support remote treatment optimization by neurologists.

Product overview

PD Neurotechnology offers the PDMonitor® as its core product—an integrated medical device ecosystem for continuous remote monitoring of Parkinson's disease symptoms. The system comprises five wearable monitoring devices, a SmartBox connection station, a mobile application, cloud-based data storage, and a web-based Physician Tool. The company has also developed HealthSonar for sleep and daily activity monitoring, and participates in research projects including the Smart Insole (for gait analysis) and PD_Pal (European project for advanced Parkinson's care management).

Differentiator

Problem solved

Functional benefit

Products and services

  • PDMonitor® A CE-marked Class IIa medical device ecosystem for continuous remote monitoring of Parkinson's disease patients. The system comprises five wearable sensors worn on different body parts (wrists and ankles), a SmartBox connection/docking station, a mobile application, cloud-based data storage, and a web-based Physician Tool. It tracks, records, and processes nine motor symptoms — bradykinesia, dyskinesia, tremor, gait disturbances, freezing of gait, orthostatic instability, ON/OFF states, activity, and fluctuations — and is used by patients at home in conjunction with a certified neurologist.

Quantifiable outcome

  • Certified 30 neurologists from 6 countries (Germany, Italy, Sweden, Ireland, Greece, Cyprus) in PDMonitor usage within a single training initiative
  • +2 more outcomes

Companies that use PD Neurotechnology

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

PD Neurotechnology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

PD Neurotechnology partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Endeavor GreececoreStrategic or Co-development Partner · 11 January 2021PD Neurotechnology was selected among 9 companies for Endeavor's Scale-Up program, gaining access to strategic guidance from specialized mentors, funding through Endeavor's international investor network, and talent through cooperation with universities and companies internationally.
  • PKNM Solutions SarlminorImplementation/ SI/ Consulting PartnerPKNM Solutions Sarl served as regulatory advisor throughout the CE certification process for PDMonitor, providing expertise on compliance with Medical Device Directive 93/42/EEC requirements.
  • PD_Pal Project ConsortiumcoreStrategic or Co-development PartnerPD Neurotechnology participates in the PD_Pal project, a multi-center European project coordinated by University of Padua, developing innovative approaches to Parkinson's care using technology integration. The 4 million Euro EU Horizon 2020 funded project involves King's College London, University College London, University of Nijmegen, University of Ioannina, University of Marburg, and Paracelsus University Salzburg.
  • HealthSonar Project ConsortiumcoreStrategic or Co-development PartnerPD Neurotechnology coordinates the HealthSonar project with partners including FORTH-IESL & ICS (Foundation of Research and Technology Hellas), NKUA (National Kapodistrian University of Athens), FORTH-IMBB, University of Patras, and Medis. The project develops a non-invasive system for monitoring sleep and healthy living using low power radio wave technologies.
  • Smart Insole Project ConsortiumminorStrategic or Co-development PartnerPD Neurotechnology participates in the Smart Insole project developing a novel wearable sensor for continuous gait analysis using innovative materials and manufacturing methods. Funded under the Greek 'RESEARCH-CREATE-INNOVATE' program with European Regional Development Fund and national resources.
  • Greek National Organization for Medicines (EOF)coreOthersPDMonitor is officially registered with the Greek National Organization for Medicines (EOF) with registration number 2820003711929, enabling legal sale as a medical product in the Greek market.

Scale indicators7 records

Recent moves8 records

Expansion highlights8 records

PD Neurotechnology competitors and assessment

Company assessment

Direct peers

  • Global Kinetics Corporation: Australian medical device company that developed the Personal KinetiGraph (PKG) wearable watch for objective, continuous measurement of Parkinson's disease motor symptoms. Direct competitor offering a similar wearable monitoring solution targeting neurologists and movement disorder specialists, with established commercial traction in multiple geographies.
  • Great Lakes NeuroTechnologies: US-based company commercializing the Kinesia family of wearable sensors and software for quantitative assessment of Parkinson's disease motor symptoms. Direct competitor with FDA-cleared products, serving movement disorder clinics and clinical trials with similar kinematic-data-driven symptom monitoring.
  • Cala Health: US medical device company developing wearable neurostimulation therapies (Cala Trio, Cala kIQ) for essential tremor and Parkinson's disease. Direct competitor in the wearable neurology space targeting the same Parkinson's patient population, though focused on therapeutic stimulation rather than monitoring.
  • Charco Neurotech: UK-based startup developing the CUE1 wearable device for Parkinson's disease symptom relief through focused vibrotactile stimulation. Direct peer operating in the same wearable Parkinson's category from a UK base, targeting the same patient and specialist community with adjacent therapeutic wearable approach.

Emerging players

  • Rune Labs: US digital health company offering StrivePD, an Apple Watch-based Parkinson's monitoring and care platform with FDA clearance and pharma partnerships. Emerging competitor leveraging consumer device distribution rather than proprietary hardware, which represents a different but overlapping approach to continuous Parkinson's symptom monitoring.
  • Sensodiag: French medical device startup developing wearable sensors and AI algorithms for continuous monitoring of Parkinson's disease motor symptoms. Emerging European peer with overlapping wearable/ML approach to objective PD assessment, competing for similar clinical and research customers.

Broad incumbents

  • Medtronic: Global medical device leader with deep involvement in Parkinson's disease through deep brain stimulation (DBS) systems and increasingly connected care/digital health platforms. Broad incumbent providing an alternative interventional treatment path and increasingly adjacent digital monitoring for PD patients.
  • AbbVie: Global pharmaceutical leader in Parkinson's disease therapeutics (Duopa, Duodopa, Vyalev) and major funder of clinical research including digital biomarker programs. Broad incumbent representing both a competitor in adjacent digital PD solutions and a potential pharma-channel partner for clinical trial endpoints.
  • Roche: Global pharmaceutical and diagnostics leader with growing investment in digital health, including the PD Digital Biomarker DREAM Challenge and partnerships around objective Parkinson's measurement. Broad incumbent operating at the intersection of diagnostics and digital biomarkers relevant to PD monitoring.

Others

  • Michael J. Fox Foundation for Parkinson's Research: Major Parkinson's disease research foundation that funds digital biomarker development, wearable validation studies, and clinical consortia. Acts as an ecosystem participant rather than competitor — relevant because it influences payer validation, research collaborations, and clinical study design across the wearable PD monitoring space.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

PD Neurotechnology social profiles

Digital presence

PD Neurotechnology compliance and trust

Trust signal

Compliance6 records

PD Neurotechnology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PD Neurotechnology leadership team

Management profile

Number of profiles

Profiles4 records

PD Neurotechnology funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PD Neurotechnology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PD Neurotechnology

What does PD Neurotechnology do?

PD Neurotechnology develops and sells PDMonitor®, a CE-marked Class IIa medical device ecosystem that continuously monitors Parkinson's disease symptoms in patients' homes. The system consists of five wearable sensors (worn on wrists and ankles), a SmartBox docking station, a mobile application, cloud-based data storage, and a web-based Physician Tool for clinicians. Data is processed through proprietary algorithms and machine learning to objectively track nine motor symptoms and support remote treatment optimization by neurologists.

Is PD Neurotechnology a public or private company?

PD Neurotechnology is a private company. It is classified as venture growth investor backed and is currently operating.

When was PD Neurotechnology founded?

PD Neurotechnology was founded in 2015. It employs 11 to 50 people.

Where is PD Neurotechnology based?

PD Neurotechnology is headquartered in London, United Kingdom, in the Europe region.

How does PD Neurotechnology make money?

Three revenue lines are on record. PDMonitor Device Sales are the primary driver. The others are cloud Platform and Software Services and healthSonar System.

Who are PD Neurotechnology's main competitors?

Direct peers on record are Global Kinetics Corporation, Great Lakes NeuroTechnologies, Cala Health and Charco Neurotech. Emerging players are Rune Labs and Sensodiag. Broad incumbents are Medtronic, AbbVie and Roche. Michael J. Fox Foundation for Parkinson's Research is listed as an others.

Does PD Neurotechnology have an API?

No public API is recorded for PD Neurotechnology.

What industry is PD Neurotechnology in?

PD Neurotechnology's product category is Wearable Medical Devices — Parkinson's Disease Monitoring. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLALAFAJ, Neurology RPM (epilepsy, Parkinson’s, MS monitoring). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals